blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0341904

EP0341904 - Method for predicting the effectiveness of antineoplastic therapy in individual patients [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.02.1996
Database last updated on 21.05.2024
Most recent event   Tooltip30.10.2009Change - representativepublished on 02.12.2009  [2009/49]
Applicant(s)For all designated states
Temple University - Of The Commonwealth System of Higher Education
1801 North Broad Street Philadelphia
Pennsylvania 19122 / US
[N/P]
Former [1989/46]For all designated states
Temple University of the Commonwealth System of Higher Education
1801 North Broad Street
Philadelphia Pennsylvania 19122 / US
Inventor(s)01 / Gewirtz, Alan M.
837 North 24th Street
Philadelphia PA 19130 / US
02 / Calabretta, Bruno
2401 Pine Street
Philadelphia PA 19103 / US
[1989/46]
Representative(s)Ackroyd, Robert, et al
WP Thompson
138 Fetter Lane
London EC4A 1BT / GB
[N/P]
Former [2009/49]Ackroyd, Robert, et al
W.P. Thompson & Co. Eastcheap House Central Approach Letchworth
Hertfordshire SG6 3DS / GB
Former [1994/33]Ackroyd, Robert, et al
W.P. THOMPSON & CO. Eastcheap House Central Approach
Letchworth, Hertfordshire SG6 3DS / GB
Former [1989/46]Ackroyd, Robert
W.P. THOMPSON & CO. Celcon House 289-293 High Holborn
London WC1V 7HU / GB
Application number, filing date89304494.104.05.1989
[1989/46]
Priority number, dateUS1988019144909.05.1988         Original published format: US 191449
[1989/46]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0341904
Date:15.11.1989
Language:EN
[1989/46]
Type: A3 Search report 
No.:EP0341904
Date:27.11.1991
Language:EN
[1991/48]
Type: B1 Patent specification 
No.:EP0341904
Date:29.03.1995
Language:EN
[1995/13]
Search report(s)(Supplementary) European search report - dispatched on:EP04.10.1991
ClassificationIPC:C12Q1/68
[1989/46]
CPC:
C12Q1/6897 (EP,US); C12Q1/6886 (EP,US); C12Q2600/106 (EP,US);
Y10S436/813 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1989/46]
TitleGerman:Verfahren zur Voraussage der Wirksamkeit einer antineoplastichen Behandlung bei einzelnen Patienten[1989/46]
English:Method for predicting the effectiveness of antineoplastic therapy in individual patients[1989/46]
French:Procédé pour prédire l'effectivité d'une thérapie antinéoplasique chez des malades individuels.[1995/13]
Former [1989/46]Procédé pour prédire l'effectivité d'une thérapie antinéoplastique chez des malades individuels
Examination procedure07.05.1992Examination requested  [1992/30]
13.09.1993Despatch of a communication from the examining division (Time limit: M04)
26.11.1993Despatch of a communication from the examining division (Time limit: M04)
23.03.1994Reply to a communication from the examining division
13.06.1994Despatch of communication of intention to grant (Approval: No)
20.09.1994Despatch of communication of intention to grant (Approval: later approval)
23.09.1994Communication of intention to grant the patent
22.12.1994Fee for grant paid
22.12.1994Fee for publishing/printing paid
Opposition(s)30.12.1995No opposition filed within time limit [1996/12]
Fees paidRenewal fee
30.05.1991Renewal fee patent year 03
11.05.1992Renewal fee patent year 04
10.05.1993Renewal fee patent year 05
02.05.1994Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT29.03.1995
BE29.03.1995
CH29.03.1995
ES29.03.1995
GR29.03.1995
IT29.03.1995
LI29.03.1995
NL29.03.1995
LU31.05.1995
SE29.06.1995
[2003/11]
Former [2002/24]AT29.03.1995
BE29.03.1995
CH29.03.1995
ES29.03.1995
GR29.03.1995
IT29.03.1995
LI29.03.1995
LU31.05.1995
NL31.05.1995
SE29.06.1995
Former [2000/27]AT29.03.1995
BE29.03.1995
CH29.03.1995
GR29.03.1995
IT29.03.1995
LI29.03.1995
LU31.05.1995
NL31.05.1995
SE29.06.1995
Former [2000/04]AT29.03.1995
BE29.03.1995
CH29.03.1995
GR29.03.1995
IT29.03.1995
LI29.03.1995
LU31.05.1995
SE29.06.1995
Former [1999/42]AT29.03.1995
BE29.03.1995
CH29.03.1995
IT29.03.1995
LI29.03.1995
SE29.06.1995
Former [1997/17]AT29.03.1995
BE29.03.1995
CH29.03.1995
LI29.03.1995
SE29.06.1995
Former [1996/04]AT29.03.1995
BE29.03.1995
CH29.03.1995
LI29.03.1995
SE29.06.1995
Former [1996/02]AT29.03.1995
CH29.03.1995
LI29.03.1995
Former [1995/44]CH29.03.1995
LI29.03.1995
Documents cited:Search[AP]EP0290144  (HOPE CITY [US])
 [X]  - Cancer Research vol. 47, no. 17, 01 September 1987, Chicago Ill. pages 4544 - 4547; Tonini et al.: "Erythroid differentiation and modulation of c-myc expression induced by antineoplastic drugs in the human leukemic cell line K562"
 [AD]  - Proceedings of the National Academy of Sciences vol. 82, July 1985, Baltimore Md. pages 4463 - 4467; Calabretta et al.: "Cell-cycle-specific genes differentially expressed in human leukemias"
 [AD]  - Cell vol. 35, December 1983, Cambridge Mass. pages 603 - 610; Kelly et al.: "Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platlet-derived growth factor"
 [AD]  - Biochemistry Suppl. 11A Abstract D510 1987, page 237 H.D. Preisler: "Clinical relevance of proto-oncogene expression "
 [AD]  - Cancer Research vol. 47, 01 February 1987, Chicago Ill. pages 874 - 880; Preisler et al.: "Expression of the protooncogenes c-myc, c-fos, and c-fms in acute myelocytic leukemia at diagnosis and in remission"
 [XP]  - Proceedings of the National Academy of Sciences vol. 85, no. 10, May 1988, Washington DC pages 3590 - 3594; Venturelli et al.: "Prognostic significance of "short-term" effects of chemotherapy on MYC and histone H3 mRNA levels in acute leukemia patients"
Examination   - BIOCHEMISTRY, suppl. 11A, 1987; H.D. PREISLER, p. 237, no. D510#
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.